Your browser doesn't support javascript.
Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review.
Vassallo, Amy; Dunbar, Kimberly; Ajuwon, Busayo; Lowbridge, Christopher; Kirk, Martyn; King, Catherine; Sheel, Meru.
  • Vassallo A; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Dunbar K; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Ajuwon B; National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Canberra, Australian Capital Territory, Australia.
  • Lowbridge C; National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Canberra, Australian Capital Territory, Australia.
  • Kirk M; Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
  • King C; National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Canberra, Australian Capital Territory, Australia.
  • Sheel M; The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
BMJ Glob Health ; 6(11)2021 11.
Article in English | MEDLINE | ID: covidwho-1515292
ABSTRACT

INTRODUCTION:

The Global Polio Eradication Initiative uses polio supplementary immunisation activities (SIAs) as a strategy to increase vaccine coverage and cease poliovirus transmission. Impact of polio SIAs on immunisation systems is frequently debated. We reviewed the impact of polio SIAs on routine immunisation and health systems during the modern era of polio eradication.

METHODS:

We searched nine databases for studies reporting on polio SIAs and immunisation coverage, financial investment, workforce and health services delivery. We conducted a narrative synthesis of evidence. Records prior to 1994, animal, modelling or case studies data were excluded.

RESULTS:

20/1637 unique records were included. Data on vaccine coverage were included in 70% (14/20) studies, workforce in 65% (13/20) and health services delivery in 85% (17/20). SIAs positively contributed to vaccination uptake of non-polio vaccines in seven studies, neutral in three and negative in one. Some polio SIAs contributed to workforce strengthening through training and capacity building. Polio SIAs were accompanied with increased social mobilisation and community awareness building confidence in vaccination programmes. Included studies were programmatic in nature and contained variable data, thus could not be justly critically appraised.

CONCLUSION:

Polio SIAs are successful at increasing polio vaccine coverage, but the resources and infrastructures were not always utilised for delivery of non-polio vaccines and integration into routine service delivery. We found a gap in standardised tools to evaluate SIAs, which can then inform service integration. Our study provides data to inform SIAs evaluations, and provides important considerations for COVID-19 vaccine roll-out to strengthen health systems. PROSPERO REGISTRATION NUMBER CRD42020152195.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Poliomyelitis / COVID-19 Type of study: Experimental Studies / Observational study / Reviews / Systematic review/Meta Analysis Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-006568

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Poliomyelitis / COVID-19 Type of study: Experimental Studies / Observational study / Reviews / Systematic review/Meta Analysis Topics: Vaccines Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Bmjgh-2021-006568